Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma: Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: evaluation report
Cited by National Institute for Health and Care Excellence on
The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.